Implantable therapeutic substance delivery system with catheter access port control and method of use

• US 20070255233A1
• Filed: 04/28/2006
• Published: 11/01/2007
• Est. Priority Date: 04/28/2006
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Haase, James
• Granted Patent: US 8,100,871 B2
• Time in Patent Office: Days
• US Class Current: 604/288.10
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/16881 Regulating valves on-off valves, e.g. clamps A61M39/28

Abstract

A drug pump including a housing, reservoir, access port, flow restrictor mechanism, and refill port. The housing defines a discharge outlet, and maintains the reservoir in fluid communication with the refill port. The access port is fluidly connected to the discharge outlet. The flow restrictor mechanism is fluidly connected between the discharge outlet and the access port, positioned to establish outflow and inflow directions. The flow restrictor mechanism has flow restriction characteristics in the outflow direction that differ from flow restriction characteristics in the inflow direction. The flow restrictor mechanism partially restricts fluid flow in the outflow direction such that a clinician can sense a difference between an available injection rate through the access port as compared to through the refill port. Further, the flow restrictor mechanism does not overtly impede fluid withdrawal procedures via the access port.

Claims

1. A human implantable liquid therapeutic substance delivery system comprising:

a delivery device including;

a housing defining a discharge outlet;

a reservoir maintained by the housing for containing the therapeutic substance;

an access port assembly fluidly connected to the discharge outlet via a fluid pathway;

a flow restrictor mechanism fluidly connected between the discharge outlet and the access port assembly so as to establish, relative to the discharge outlet, an outflow fluid flow direction and an inflow fluid flow direction, the flow restriction mechanism configured to have flow restriction characteristics in the outflow direction that differ from flow restriction characteristics in the inflow direction; and

a refill port assembly apart from the access port assembly and fluidly connected to the reservoir.

2. The system of claim 1, wherein the reservoir includes a reservoir inlet fluidly connected to the refill port assembly and a reservoir outlet, and further wherein the reservoir outlet is fluidly connected to the fluid pathway.

3. The system of claim 2, wherein the delivery device further includes a metering mechanism fluidly connected to the reservoir outlet.

4. The system of claim 3, wherein the metering mechanism is fluidly connected to the discharge outlet.

5. The system of claim 4, wherein the flow restrictor mechanism is fluidly connected between the metering mechanism and the discharge outlet.

6. The system of claim 1, further comprising:

an implantable catheter fluidly connected to the discharge outlet for delivering liquid introduced at the access port assembly such that the access port assembly is a catheter access port assembly.

7. The system of claim 1, wherein the flow restrictor mechanism is self-actuating.

8. The system of claim 1, wherein the flow restrictor mechanism is configured to provide a first effective orifice size in a first state, and a second effective orifice size in a second state, the first effective orifice size being less than the second effective orifice size, and further wherein the flow restrictor mechanism is biased to the first state.

9. The system of claim 8, wherein the flow restrictor mechanism is configured to maintain the first state in the presence of fluid flow in the outflow direction.

10. The system of claim 9, wherein the flow restrictor mechanism is configured to transition from the first state to the second state in the presence of fluid flow in the inflow direction.

11. The system of claim 9, wherein the flow restrictor mechanism is configured to transition from the first state to the second state in the presence of a vacuum formed in the access port assembly.

12. The system of claim 1, wherein the flow restrictor mechanism includes a valve plate defining an orifice, a cylinder forming an inlet face having an inlet opening and outlet face having an outlet opening and slidably maintaining the valve plate between a first position in which the valve plate is fluidly sealed relative to the one of the inlet and outlet faces such that fluid flow through the flow restrictor mechanism is restricted to the orifice, and a second position in which the valve plate is not fluidly sealed relative to the outlet and inlet faces in which fluid flow through the flow restrictor mechanism is not restricted to the orifice, and a biasing device for biasing the valve plate to the first position.

13. The system of claim 12, wherein a diameter of the orifice is less than a diameter of the inlet opening or the outlet opening.

14. The system of claim 12, wherein the biasing device is a spring having a spring force selected to allow movement of the valve plate away from the outlet face when a pressure exerted upon the valve plate in the inflow direction exceeds a predetermined value.

15. A method of percutaneously performing a liquid substance exchange with an implantable therapeutic substance delivery device including a housing maintaining a reservoir for containing the therapeutic substance, a refill port assembly fluidly connected to the reservoir, and an access port assembly fluidly connected to a discharge port, the method comprising:

providing a flow restrictor mechanism fluidly connected between the access port assembly and the discharge outlet, the flow restrictor mechanism adapted to present a restriction to fluid flow from the access port assembly to the discharge port;

providing a liquid supply assembly including a needle fluidly connected to a supply of liquid, the needle terminating in a needle tip;

percutaneously delivering the needle tip through a septum associated with one of the refill port assembly and the access port assembly;

initiating injection of liquid through the needle;

determining whether the needle tip is disposed within the refill port assembly or the access port assembly based upon a sensed resistance to fluid flow through the needle tip while injecting the liquid through the needle; and

determining whether to move the needle tip from the port assembly within which the needle tip is currently positioned based upon the sensed resistance to fluid flow.

16. The method of claim 15, wherein the method relates to refilling the reservoir with therapeutic substance.

17. The method of claim 15, wherein determining whether the needle tip is disposed within the refill port assembly is based upon a perceived flow rate from the needle tip.

18. The method of claim 15, further comprising:

providing a liquid withdrawal system including a withdrawal needle terminating in a tip;

percutaneously inserting the withdrawal needle tip into the access port assembly and beyond the access port assembly septum;

creating a vacuum in the access port assembly via the needle tip to cause the flow restrictor mechanism to transition from a first state to a second state; and

withdrawing liquid from the patient, through the discharge opening and the access port assembly with the flow restrictor mechanism in the second state.

19. A human implantable therapeutic substance delivery system comprising:

a delivery device including;

a housing defining a discharge outlet;

a reservoir maintained by the housing for containing the therapeutic substance;

an access port assembly fluidly connected to the discharge outlet via fluid pathway;

a refill port assembly apart from the access port assembly and fluidly connected to the reservoir; and

flow restriction means for partially restricting a rate of fluid flow across the fluid pathway at least in a direction from the access port assembly to the discharge outlet, the flow restriction means adapted to permit fluid flow from the discharge outlet to the access port assembly.

20. The system of claim 19, wherein the flow restriction means is a self-actuating valve means.

21. The system of claim 19, wherein the flow restriction means is configured such that a maximum flow rate from the discharge outlet to the access port assembly is greater than a maximum flow rate from the access port assembly to the discharge outlet.

22. The system of claim 19, wherein the flow restriction means is adapted such that a maximum flow rate from the access port assembly to the discharge outlet is at least three times less than a maximum flow rate from the refill port assembly to the reservoir.

23. The system of claim 19, wherein the flow restriction means provides a fluid flow conduit having a diameter of approximately 0.005 inch in a flow direction from the access port assembly to the discharge outlet.